ISGF3komplexet

ISGF3komplexet, or the interferon-stimulated gene factor 3 complex, is a crucial transcription factor complex in eukaryotic cells. It plays a central role in the JAK-STAT signaling pathway, which is activated in response to interferons (IFNs), cytokines that are critical for the immune response against viral infections and other pathogens. The complex is primarily responsible for inducing the expression of a large number of interferon-stimulated genes (ISGs), which collectively form the antiviral state and help to limit viral replication.

The ISGF3 complex is composed of three main proteins: IRF9 (also known as ISGF3γ), STAT2 (STAT1-like protein), and STAT1 (STAT1). In addition to these, the complex requires the coactivator p48 (also known as IRF9 or ISGF3α), which is a member of the interferon regulatory factor (IRF) family. The assembly of the complex is mediated by the phosphorylation of STAT1 and STAT2 by JAK kinases (Janus kinases) in response to IFN signaling. This phosphorylation creates binding sites for IRF9, leading to the formation of the active transcriptional complex.

Once activated by IFN signaling, the JAK kinases phosphorylate STAT1 and STAT2. These phosphorylated STAT proteins then dimerize and bind to IRF9, forming the ISGF3 complex. The complex then translocates to the nucleus and binds to specific DNA sequences called interferon-stimulated response elements (ISREs) in the promoters of ISG genes. This binding recruits additional coactivators and chromatin remodeling complexes, leading to the transcriptional activation of these genes.

The activation of ISGF3 and the subsequent induction of ISGs are essential for the host's antiviral defense. ISGs encode proteins with various functions, including protein kinase activation, oligoadenylate synthetase activity, and the production of antiviral proteins such as 2'-5' oligoadenylate synthetase and Mx proteins. By upregulating these genes, the cell can inhibit viral replication, enhance the presentation of viral antigens to the immune system, and limit the spread of infection. Dysregulation of the ISGF3 pathway has been implicated in various diseases, including cancer and autoimmune disorders.